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Abstract
The Diabetes Indicators and Data Sources Internet Tool
(DIDIT) is an interactive Web-based resource with infor-
mation on 38 diabetes indicators (e.g., diabetes-associated
complications, care, lifestyle) and 12 associated data
sources frequently used by state diabetes prevention and
control programs. This tool is designed to strengthen the
ability of states to conduct diabetes surveillance and to
promote consistency in defining and tracking indicators
across states. In this way, the DIDIT supports one of the
10 essential public health services: the timely and accurate
assessment of public health.
In addition to serving as a central repository of informa-
tion on diabetes surveillance, the DIDIT also allows users
to share experiences of using these indicators and data
sources in their diabetes surveillance activities, data
analysis, and tracking of diabetes-related objectives stated
by  Healthy People 2010. The DIDIT is an innovative
approach to enhancing public health surveillance at the
state and national levels.
Introduction
Diabetes is a complex, chronic disease consisting of a
group of conditions resulting from the impaired production
or effectiveness of insulin (1). It is increasingly important
to conduct surveillance to accurately assess the prevalence
of diabetes and its complications. The global prevalence of
diabetes is nearly 200 million cases, and there is a sense
of urgency in the public health field about understanding
and defining the burden of diabetes and its associated risk
factors (2). Traditionally, diabetes surveillance has includ-
ed monitoring indicators such as incidence, prevalence,
complications, mortality, quality of care, and preventive-
care practices (3). Reflecting recent developments in the
identification of risk factors for type 2 diabetes (4,5), sur-
veillance has expanded to include lifestyle variables such
as diet and physical activity (6), socioeconomic status (7),
quality of life (8), and a condition called prediabetes.
People who have blood glucose levels that are higher than
normal, but not high enough to be classified as diabetes,
have prediabetes (4).
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The Centers for Disease Control 
and Prevention’s (CDC’s) National
Diabetes Prevention and Control
Program (NDPCP) supports a Diabetes
Prevention and Control Program
(DPCP) in each state, each U.S. terri-
tory, and the District of Columbia. The
NDPCP and the 59 DPCPs are charged
with defining and monitoring the bur-
den of diabetes and demonstrating suc-
cess in accomplishing NDPCP national
objectives, which were established in
1999 to reduce preventable morbidity
and mortality associated with diabetes.
These objectives incorporate goals to
increase the proportion of people with
diabetes who receive annual foot exam-
inations, dilated eye examinations,
hemoglobin A1c (HbA1c) tests, and rec-
ommended vaccinations against
influenza and pneumococcal infection.
The national objectives also address
reducing health disparities for popula-
tions at high risk for diabetes and
establishing links with other programs
that promote wellness among people with diabetes (10).
Additionally, the timely and accurate assessment of pub-
lic health is one of the 10 essential public health services
and thus a fundamental function of public health agencies,
such as DPCPs, that are responsible for population-based
health (11). The DPCPs also track and strive to achieve
Healthy People 2010 objectives, 17 of which directly
address diabetes (12).
Surveillance is essential to effective program plan-
ning, advocacy, and evaluation, and surveillance data
contribute significantly to developing and carrying out
policies at the national and state levels. Surveillance is
the continuous monitoring or routine collection of data
on various factors (e.g., behaviors, complications,
deaths) over a regular interval of time, and surveillance
data can be useful for program evaluation. In contrast,
evaluation provides tailored information to answer 
specific questions about a program. Data collection for
evaluation is more flexible than for surveillance and
may allow specific program areas to be assessed in
greater depth (13).
The NDPCP requires each DPCP to
establish a diabetes surveillance sys-
tem to monitor the burden of diabetes
within its state and systematically
evaluate the impact of DPCP pro-
grams on the morbidity and mortality
associated with diabetes. The 59
DPCPs differ in their resources, fund-
ing levels, expertise, priorities,
staffing, and partnerships. These 
factors affect a program’s ability to col-
lect, analyze, and interpret data and to
conduct surveillance and evaluate 
programs. A diabetes-specific central-
ized resource providing comprehensive
background information on definitions
of indicators, data sources, methodolo-
gy, and issues relevant to analysis is
important to achieving these surveil-
lance and evaluation goals.
In the fall of 2001, representatives
from NDPCP and five of the 59 DPCPs
formed a work group that began devel-
oping a tool to assist the DPCPs with
surveillance and program evaluation. The result was the
Diabetes Indicators and Data Sources Internet Tool
(DIDIT), which was developed to strengthen the DPCPs’
ability to conduct surveillance and program evaluation.
The DIDIT is an interactive resource that provides com-
prehensive information on 38 indicators of diabetes and
their data sources. Although most of the materials 
found in the DIDIT are available elsewhere (e.g.,
www.cdc.gov/diabetes/statistics/index.htm; www.cdc.gov/
brfss), the intent of the DIDIT is to offer, in a centralized
location, the most recent information on diabetes surveil-
lance. Another goal is to present clear, concise, and easy-
to-read information by organizing it into a flexible and an
interactive format. In addition to providing information on
38 diabetes indicators (Figure 1) and other associated data
sources (if available) for each indicator, the DIDIT pro-
vides information such as lists of related articles, Web site
links, and recommended standards of care. Updated on an
ongoing basis, the DIDIT facilitates communication in the
diabetes community by allowing for user feedback and
comments about indicators and data sources. In addition,
users have the opportunity to share their general experi-
ences with using the tool. In this article, we describe the
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Figure 1. List of all indicators in the Diabetes
Indicators and Data Sources Internet Tool
(DIDIT) by type.DIDIT’s content, provide examples of
how its information is presented, and
highlight its public health applications.
We provide an overview of the process
used to develop the DIDIT; a compre-
hensive description of the DIDIT devel-
opment process will be published in a
companion article.
Developing the DIDIT
The DIDIT was developed by the
members of a work group representing
DPCPs and the NDPCP. The work
group members have extensive expert-
ise in diabetes surveillance and evalua-
tion. User input has also been obtained
from additional DPCPs through 1)
focus groups, 2) usability testing, and
3) pilot testing, which the NDPCP con-
ducted with volunteer DPCPs before
the DIDIT’s release. Content and Web
site development are supported by two
independent contractors. To facilitate
content development, the work group
members developed a list of 55 diabetes
indicators and, using two rounds of
Delphi process, ranked them based on
importance, mutability, and availabili-
ty of state-level data. In this way, the
DIDIT’s 38 indicators were selected.
The national- and state-level data
sources described in the DIDIT were
selected because they are publicly
available, reliable, and accurate as a
result of quality assurance procedures
in place at the various agencies that
maintain them (e.g., the CDC, the
Agency for Healthcare Research and
Quality, and the Centers for Medicare
and Medicaid.) The first version of the
DIDIT was released to DPCPs in
October 2003. In April 2004, the DPCP
staff and the NDPCP project officers
were trained to use the DIDIT using NetMeeting
(Microsoft Corp, Redmond, Wash), which allowed for a
two-way interaction between stakeholders in various 
geographical areas.
The DIDIT is still a work in
progress, and several enhancements
are underway. The DPCPs and CDC
partners have been kept informed of
the DIDIT development and enhance-
ment on an ongoing basis through
presentations, e-mail updates, and
conference calls.
Contents of the DIDIT
Diabetes indicators
The DIDIT provides information
about each of 38 diabetes indicators
(Figure 2), including its relevance to
diabetes surveillance, NDPCP nation-
al objectives, and Healthy People 2010
objectives (12). Additionally, it pro-
vides information about the agencies
recommending the indicator, related
articles and Web sites, and a list of
associated data sources. Many of the
indicators are related to health care
practices (e.g., annual foot examina-
tions) or recommendations on lifestyle
issues for people with diabetes (e.g.,
physical activity). If relevant, informa-
tion on recommended standards of
care is provided. For example, the
American Diabetes Association’s posi-
tion statement on preventive care
practices is linked to many of 
the indicators.
Data sources
The DIDIT includes 12 frequently
used state and national data sources
for diabetes surveillance (Figure 3).
The data sources are cross-referenced
with information about the indicators.
For each indicator, the DIDIT provides
methodologies for computing the
numerator and denominator using the associated data
sources. In addition, DPCPs can enter and share informa-
tion about a DPCP-specific data source to inform others of
special methods for collecting local data. As of April 2005,
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Figure 2. Information in the Diabetes Indicators
and Data Sources Internet Tool (DIDIT) on each
of 38 diabetes indicators.
Figure 3. List of Diabetes Prevention and
Control Program-specific data sources in the
Diabetes Indicators and Data Sources Internet
Tool (DIDIT).
Figure 4. General information about the End
Stage Renal Disease Networks data source that
is included in the Diabetes Indicators and Data
Sources Internet Tool (DIDIT).VOLUME 2: NO. 3
JULY 2005
California, Utah, and Ohio had entered
information about DPCP-specific data
sources they have used for diabetes
surveillance (Figure 3). The DIDIT
data sources include surveys (e.g.,
Behavioral Risk Factor Surveillance
System [BRFSS], National Health
Interview Survey [NHIS]), administra-
tive records (e.g., health insurance
claims), and vital records (e.g., death
and birth certificates). These data are
collected by various methods, such as
telephone interviews, in-person inter-
views, and laboratory testing. We
should note that the DIDIT does not
provide data but instead gives compre-
hensive information about data,
including where and how to access it.
For each data source, the DIDIT pro-
vides information on the population
represented by the data, the method
and purpose of data collection, access
issues, privacy issues, and general ana-
lytic issues, in addition to providing a
list of diabetes indicators that can be
tracked using that data source (Figure
4). The DIDIT is designed to provide
users with the information needed to
use a data source effectively. Thus, the
DIDIT serves as a reference guide for
learning about and using key data
sources for diabetes surveillance. The
DIDIT also has a search feature, allow-
ing users to search for specific data
sources, indicators, or both.
Specification of numerators and
denominators
Standardization in computing and
reporting estimates across states is
essential to high-quality diabetes sur-
veillance. Any differences in calculat-
ing the numerator or denominator of an indicator at the
state level can cause variations, making it difficult to com-
pare data over time or across states.
The DIDIT provides instructions for constructing
numerators and denominators of indicators (Figure 5) for
each data source linked to each indica-
tor. For example, state-level data on
HbA1c testing is available from
sources such as the Health Plan
Employer Data and Information Set
(HEDIS), BRFSS, Medicare, and
Medicaid. The DIDIT provides infor-
mation about computing the numera-
tor and denominator for HbA1c testing
using each of these four data sources.
It provides information on which cases
should be included in the numerator
and denominator in addition to rele-
vant diagnosis and procedure codes
where appropriate (e.g., for adminis-
trative and inpatient hospital dis-
charge data). For survey data, relevant
survey questions are provided (Figure
5), allowing users to analyze and
report diabetes indicators consistently
with other programs. All of this infor-
mation allows users to compare differ-
ent potential data sources and decide
which are best suited for their pro-
gram needs and how to correctly
define the numerator and denomina-
tor for data analysis.
Technical issues in analysis
Data analysis can be complex, and
most people learn about its pitfalls
through trial and error. A unique fea-
ture of the DIDIT is the technical notes
field, which provides background
information and caveats for analyzing
data for an indicator and a data source
(Figure 6).
Furthermore, the DIDIT encourages
users to share experiences in analyz-
ing indicators and data sources. By
using the comments view/add feature
(Figure 4) and posting their comments on the DIDIT, users
can inform their peers about technical issues related to
diabetes data analysis. This interactive feature of the
DIDIT sets up an avenue for sharing, documenting, and
learning. Currently, all DPCPs can enter this information
about their own or their partners’ experiences.
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Figure 5.  General and diabetes indicator-spe-
cific information provided by the Behavioral Risk
Factor Surveillance System (BRFSS) data
source that is included in the Diabetes
Indicators and Data Sources Internet Tool
(DIDIT).
Figure 6. Information to construct the inci-
dence of end-stage renal disease attributed to
diabetes indicators using the End Stage Renal
Disease Networks data source.At a Glance
The  At a Glance function in the
DIDIT provides a snapshot of the rela-
tionship between indicators and their
data sources. For example, in Figure 7,
the 38 indicators are presented in the
first column, with their national- and
state-level data sources presented in
the second and third columns. This lay-
out allows users to quickly assess the
number and names of data sources
available in the DIDIT for each indica-
tor. Similarly, the DIDIT presents
another table with the 12 data sources
listed in the first column and the indi-
cators that can be measured with each
data source in the second column
(Figure 8).
Upcoming Enhancements
and Activities
In its current capacity, the DIDIT is
a powerful tool, but it continues to
evolve in response to the needs of the
NDPCP and DPCPs. Thus, the DIDIT
is a work in progress. While we work
on populating the current fields,
efforts are underway to enhance the
tool by adding a glossary of epidemiol-
ogy and surveillance terms, links to
useful references, and a section called
Resources that lists background mate-
rials frequently used by epidemiolo-
gists. We plan to update the DIDIT
content as needed and develop 
an online training curriculum.
Additionally, we plan to evaluate the
DIDIT to ensure that it is meeting the
needs of DPCPs and their partners.
Using the DIDIT for Program
Evaluation Activities
An additional function of the DIDIT
is to assist in evaluating public health
programs. The information provided in
the DIDIT can address steps 3–5 of the
CDC’s 6-step framework for program
evaluation (14). For example, if a DPCP
is planning to evaluate the increase in
the percentage of people with diabetes
who receive the recommended eye
examination, they might use the DIDIT
to help them and their community part-
ners understand the reason it is impor-
tant to track eye examinations among
people with diabetes and how this indi-
cator is defined. Next, using informa-
tion on available data sources, they
would identify data sources for tracking
eye examinations (e.g., BRFSS,
HEDIS) and use the descriptive infor-
mation about each data source to select
the best data source for their purpose.
Using information in the indicator-spe-
cific section, they would construct their
numerator and denominator for eye
examinations in a way that is consis-
tent with methods used by other
DPCPs. The information in technical
notes would help them analyze the data
and interpret their conclusions.
Implications for Public
Health Practice
Effective public health surveillance
requires access to timely, accurate, and
reliable information from a wide vari-
ety of sources (3). The DIDIT is a valu-
able resource for helping public health
practitioners and clinical staff to assess
the burden, complications, and risk fac-
tors of diabetes.
The DIDIT is the only reference tool
of its kind that contains diabetes-spe-
cific information required for surveil-
lance and, to some extent, for program
evaluation activities. This comprehen-
sive resource saves time because
DIDIT users do not have to search 
for information on several Web sites 
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Figure 7. List of diabetes indicators and their
associated national-, state-, and Diabetes
Prevention and Control Program (DPCP)-specific
data sources.
Figure 8. List of Diabetes Indicators and Data
Sources Internet Tool (DIDIT) data sources by
type and related indicators.VOLUME 2: NO. 3
JULY 2005
or read lengthy descriptions to find information 
on diabetes.
The information about indicators has numerous poten-
tial uses. People new to diabetes surveillance can use the
information to become familiar with multiple aspects of
each indicator. The information also assists experienced
public health practitioners by helping them work with new
indicators or stay current on the most recent diabetes
information, such as the latest position statement of the
American Diabetes Association. Having a list of related
peer-reviewed articles, summaries, or Web sites for each
indicator saves users the effort of searching the literature.
Informally, some users have reported using information
and resources from the description pages on various indi-
cators to prepare presentations, write articles, and locate
and develop educational materials.
The DIDIT provides a common platform and language
for epidemiologists, state program coordinators, the CDC’s
Division of Diabetes Translation, and project officers to
communicate about issues on diabetes surveillance and
analysis. In addition, it is designed to promote national
uniformity in collecting and defining data and computing
diabetes indicators. Finally, it provides a mechanism for
DPCPs to share their unique state and local data sources,
in addition to their own experiences with using and ana-
lyzing diabetes indicators and data sources.
The concepts and participatory processes used for the
DIDIT’s development were designed to be user friendly
and can be applied to many areas of public health practice.
They also may be used to develop information technology
solutions for other diseases, public health settings, or pro-
gram areas. The DIDIT serves as a model approach for
other local, state, and national public health programs
interested in enhancing their and their partners’ technical
and scientific ability by emphasizing collective experience
and information technology. Additionally, the DIDIT pro-
vides a template that may be applied to other chronic dis-
ease programs at the CDC.
Access to the DIDIT
The DIDIT is currently accessible to all NDPCP and
DPCP staff through the Diabetes Management
Information System. To ensure data integrity and securi-
ty, this system is password protected on a secure site.
Individuals in the diabetes community can request access
to the DIDIT by visiting the CDC’s Diabetes Public Health
Resource Web site (www.cdc.gov/diabetes/statistics/
index.htm) and filling out a request form. Since its release
in October 2003, more than 30 external partners have
requested and been granted access to the DIDIT.
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